David Davies MP and Peter Fox MS visited Chepstow based Creo Medical this week, the fastest growing company in Wales* and one who’s technology is reducing the need for surgical intervention for the treatment of bowel cancer.
Creo Medical’s flagship Speedboat Inject device uses advanced bipolar radiofrequency and microwave technology to endoscopically remove lesions in the colon/bowel, with the patient leaving hospital less than 24 hours after the procedure in the vast majority of cases without the need for any further treatment.
It’s proven to be an enormous success, with over 1500 patients treated across the World to date and some of the World’s best endoscopists recently undergoing Creo’s two-day training course in order to offer the new treatment to their patients.
With their headquarters shortly to double in size in order to meet the growing demands of the business, particularly in terms of manufacturing and training, the local representatives had the opportunity to see and hear for themselves the difference Creo is making worldwide, as well as question why patients in Wales are yet to benefit from the technology.
David Davies MP, the Conservative Member of Parliament for Monmouth said:
“This is an exceptional Welsh business who are already transforming lives across the globe – with clearly a lot more still to come.
“I was especially struck by the difference they are making in changing the pathways for those presenting with lesions in the bowel. I’m acutely aware of what an ordeal surgical intervention for bowel cancer can mean for patients and so to see here a company on our doorstep leading globally on a progressive alternative in this way is magnificent.
“It is, of course, a real shame that the Welsh NHS have not yet chosen to adopt this technology – with patients in England instead benefiting along with countries across most of the world from technology conceived and made here in Wales. Hopefully that can change soon – I’d hate to think of Welsh patients being at a disadvantage in terms of access to cutting edge treatment.”
Creo Medical recently also announced partnerships with surgical robotics giants Intuitive and CMR respectively, collaborations which it is hoped will bring the advantages of its advanced energy capabilities to further indications, with all the associated benefits to patients.
Peter Fox, MS for Monmouth said:
“What Creo are doing is phenomenal – taking a concept that started from a garage all those years ago and turning it into something that is truly industry leading and making an enormous difference to so many all over the World.
“The combination of engineering and scientific brilliance was clear to see – and it’s exciting to see them turning the heads of some of the most well established Medtech companies in the World with what they are doing.”
Chris Hancock, founder of Creo Medical said: “It was a pleasure to welcome our distinguished guests here today, show them around our HQ and introduce them to a range of technology which we are excited to see now treat patients on a daily basis across the globe.
“We are hopeful patients in Wales can soon be amongst those to benefit and look forward to working with local representatives and decision makers in order to help facilitate just that.”
Creo had a successful 2022 with an eight-fold increase in the sales of their core electrosurgical products and technology. Over the same period, the number of physicians trained to use the device doubled to more than 450, with an increasing pipeline of future adopters for 2023.
*Creo Medical was awarded as the fastest growing company in Wales at the 2022 Fast Growth 50 award.
